Clinical Trial for Prostate Cancer

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00076531

Enrollment

Unknown

Registered

2004-01-27

Start date

2003-12-31

Completion date

Unknown

Last updated

2008-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate, Cancer, PSA, Leuprolide

Brief summary

Phase III trial using an injectable for treatment of prostate cancer.

Interventions

DRUGLeuprolide Acetate for Injectable Suspension 22.5 mg

Study design

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

40 Years to No maximum

Healthy volunteers

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026